Molecular aspects of Huntington's disease

Journal of Neuroscience Research

Volumn 54, Issue 3, 1998, Pages 301-308

  Walling, Hobart W ^a   Baldassare, Joseph J ^a   Westfall, Thomas C ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

Basal ganglia; Cytoskeleton; Huntingtin; Neurodegeneration; Transglutaminase; Ubiquitin

Indexed keywords

CALMODULIN; GLUTAMINE; HUNTINGTIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UBIQUITIN CONJUGATING ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BASAL GANGLION; CAUDATE NUCLEUS; CHROMOSOME 4; GABAERGIC SYSTEM; HUNTINGTON CHOREA; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; TRINUCLEOTIDE REPEAT;

ANIMALS; BRAIN; HUMANS; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROTEIN BINDING; UBIQUITINS;

EID: 0032212339     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981101)54:3<301::AID-JNR1>3.0.CO;2-W     Document Type: Short Survey

References (73)

1. Albin RL, Reiner A, Andersen KD, Dure LS 4th, Handelin B, Balfour R, Whetsell WO Jr, Penney JB, Young AB (1992): Preferential loss of striato-external pallidal projection neurons in Huntington's disease. An Neurol 31:425-430.
2. Alford RL, Ashizawa T, Jankovic J, Caskey CT, Richards CS (1996): Molecular detection of new mutations, resolution of ambiguous results and complex genetic counseling issues in Huntington disease. Am J Med Genet 66:281-286.
3. Ambrose CM, Duyao MP, Barnes G, Bates GP, Lin CS, Srinidhi J, Baxendale S, Hummerich H, Lehrach H, Altherr M, Wasmuth J, Buckler A, Church D, Housman D, Berks M, Micklem G, Durbin R, Dodge A, Read A, Gusella J, MacDonald ME (1994): Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 20:27-38.
4. Andrade MA, Bork P (1995): HEAT repeats in the Huntington's disease protein. Nat Genet 11:115-116.
5. Arzberger T, Krampfl K, Leimgruber S, Weindl A (1997): Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease: An in situ hybridization study. J Neuropathol Exp Neurol 56:440-454.
6. Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM (1996): Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proc Natl Acad Sci USA 93:5037-5042.
7. Bates GP, Mangiarini L, Mahal A, Davies SW (1997): Transgenic models of Huntington's disease. Hum Mol Genet 6:1633-1637.
8. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986): Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171.
9. Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, Ge P, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1995): Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269:407-410.
10. Engelender S, Sharp AH, Colomer V, Tokito MK, Lanahan A, Worley P, Holzbauer ELF, Ross CA (1997): Huntingtin-associated protein 1 (HAP1) interacts with the p150 (Glued) subunit of dynactin. Hum Molec Genet 6:2205-2212.
11. A-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat. Prog Brain Res 99:105-123.
12. Ferrante RJ, Gutekunst CA, Perischetti F, McNeil SM, Kowall NW, Gusella JF, MacDonald ME, Beal MF, Hersch SM (1997): Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J Neurosci 17:3052-3063.
13. Ferrante RJ, Kowall NW, Beal MF, Richardson EP Jr, Bird ED, Martin JB (1985): Selective sparing of a class of striatal neurons in HD. Science 230:561-563.
14. Furtado S, Suchowersky O (1995): Huntington's disease: recent advances in diagnosis and management. Can J Neurol Sci 22:5-12.
15. Gentile V, Sepe C, Calvani M, Melone MAB, Cotrufo R, Cooper AJL, Blass JP, Peluso G (1998): Tissue transglutaminase-catalyzed formation of high molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet expansion diseases. Arch Biochem Biophys 352:314-321.
16. Goldberg AL (1995): Functions of the proteasome: The lysis at the end of the tunnel. Science 268:522-523.
17. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR (1996): Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 13:442-449.
18. Gourfinkelan I, Cancel G, Trottier Y, Devys D, Tora L, Lutz Y, Imbert G, Sandou F, Stevanin G, Agid Y, Brice A, Mandel JL, Hirsch EC (1997): Differential distribution of the normal and mutated forms of huntingtin in the human brain. Ann Neurol 45:712-719.
19. Graybiel AM (1990): Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254.
20. Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM. Schapira AH (1996): Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39:385-389.
21. Gutekunst C-A, Levey AI, Heilman CJ, Whaley WL, Yi H, Nash NR, Rees HD, Madden JJ, Hersch SM (1995): Identification and localization of huntingtin in brain and lymphoblastoid cell lines with antifusion protein antibodies. Proc Natl Acad Sci USA 92:8710-8714.
22. Haas AL, Siepmann TJ (1997): Pathways of ubiquitin conjugation. FASEB J 11:1257-1268.
23. Haddad MS, Cummings JL (1997): Huntington's disease. Psychiatr Clin North Am 20:791-807.
24. Haldeman MT, Xia G, Kasperek EM, Pickart CM (1997): Structure and function of ubiquitin conjugating enzyme E2-25K: The tail is a core-dependent activity element. Biochemistry 36:10526-10537.
25. Harper PS (1992): The epidemiology of Huntington's disease. Hum Genet 89:365-376.
26. Hodgson JG, Smith DJ, McCutcheon K, Koide HB, Nishiyama K, Dinulos MB, Stevens ME, Bissada N, Nasir J, Kanazawa I, Disteche CM, Rubin EM, Hayden MR (1996): Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum Mol Genet 5:1875-1885.
27. The Huntington's Disease Collaborative Research Group (1993): A novel gene containing a trinucleotide repeat that is unstable on Huntington's disease chromosomes. Cell 72:971-983.
28. Ikeda H, Yamaguchi M, Sugai S, Aze Y, Narumiya S, Kakizuka A (1996): Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet 13:196-202.
29. Jentsch S, Schlenker S (1995): Selective protein degradation: a journey's end within the proteasome. Cell 82:881-884.
30. Kahlem P, Green H, Djian P (1998): Transglutaminase action imitates Huntington's disease: Selective polymerization of huntingtin containing expanded polyglutamine. Mol Cell 1:595-601.
31. Kahlem P, Terre C, Green H, Djian P (1996): Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to diseases of the nervous system. Proc Natl Acad Sci USA 93:14580-14585.
32. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC, Goldberg YP, Gietz RD, Pickart CM, Hayden MR (1996): Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugating enzyme. J Biol Chem 271:19385-19394.
33. Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi-Esfarjani P, Lynn FC, Wellington C, Metzler M, Goldberg YP, Kanazawa I, Gietz RD, Hayden MR (1997): HIP1, a human homologue of S, cerevisiae S1a2p, interacts with membrane-associated huntingtin in the brain. Nat Genet 16:44-53.
34. Li SH, Hosseini SH, Gutekunst CA, Hersch SM, Ferrante RJ, Li XJ (1998a): A human HAP1 homologue: Cloning, expression, and interaction with huntingtin. J Biol Chem 273:19220-19227.
35. Li SH, Li XJ (1998b): Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum Mol Genet 7:777-782.
36. Li XJ, Li S-H, Sharp AH, Nucifora FC, Schilling G, Lanahan A, Worley P, Snyder SH, Ross CA (1995): A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378:398-402.
37. Li XJ, Sharp AH, Li SH, Dawson TM, Synder SH, Ross CA (1996): Huntingtin-associated protein (HAP1): Discrete neuronal localizations in the brain resemble those of neuronal nitric oxide synthase. Proc Natl Acad Sci USA 93:4339-4344.
38. Liu YF, Deth RC, Devys D (1997): SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes. J Biol Chem 272:8121-8124.
39. Macdonald V, Halliday GM, Trent RJ, McCusker EA (1997): Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease. Neuropathol Appl Neurobiol 23:492-495.
40. nd edn. London: WB Saunders, pp 317-357.
41. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996): Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
42. n. J Biomol Struct Dyn 15:723-744.
43. Martin JB, Gusella JF (1986): Huntington's disease: Pathogenesis and management. N Engl J Med 315:1267-1276.
44. Martin SJ, Green DR (1995): Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349-352.
45. Myers RH, Leavitt J, Farrer LA, Jagadeesh J, McFarlane H, Mastromauro CA, Mark RJ, Gusella JF (1989): Homozygote for Huntington's disease. Am J Hum Genet 45:615-618.
46. Myers RH, Vonsattel J-P, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EP, Bird ED (1991): Decreased neuronal and increased oligodendritic densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 50:729-742.
47. Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR (1995): Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811-823.
48. Page KJ, Potter L, Aronni S, Everitt BJ, Dunnett SB (1998): The expression of huntingtin-associated protein (HAP1) mRNA in developing, adult, and ageing rat CNS: Implications for Huntington's disease neuropathology. Eur J Neurosci 10:1835-1845.
49. Persichetti F, Ambrose CM, Ge P, McNeil SM, Srinidhi J, Anderson MA, Jenkins B, Barnes GT, Duyao MP, Kanaley L, Wexler NS, Myers RH, Bird ED, Vonsattel J-P, MacDonald ME, Gusella JF (1995): Normal and expanded Huntington's disease gene alleles produce distinguishable proteins due to translation across the CAG repeat. Mol Med 1:374-383.
50. Perutz MF (1996): Glutamine repeats and inherited neurodegenerative diseases: Molecular aspects. Curr Opin Struct Biol 6:848-858.
51. Perutz MF, Johnson T, Suzuki M, Finch JT (1994): Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci USA 91:5355-5358.
52. Pickart CM, Rose IA (1985): Functional heterogeneity of ubiquitin carrier proteins. J Biol Chem 260:1573-1581.
53. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995): Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci 15:3775-3787.
54. Prusiner SB, Kinley MPM, Bowman KA, Bolton DC, Bendheim PE, Groth DF. Glenner GG (1983): Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35:349-358.
55. Reddy PS, Housman DE (1997): The complex pathology of trinucleotide repeats. Curr Opin Cell Biol 9:364-372.
56. Roos RAC, Bots GTAM (1983): Nuclear membrane indentations in Huntington's chorea. J Neurol Sci 61:37-47.
57. Rubinsztein DC, Leggo J, Coles R, Almqvist E, Biancalana V, Cassiman J-J, Chotai K, Connarty M, Craufurd D, Curtis A, Curtis D, Davidson MJ, Differ A-M, Dode C, Dodge A, Frontali M, Ranen NG, Stine OC, Sherr M, Abbott MH, Franz ML, Graham CA, Harper PS, Hedreen JC, Jackson A, Kaplan J-C, Losekoot M, MacMillan JC, Morrison P, Trottier Y, Novelletto A, Simpson SA, Theilmann J, Whittaker JL, Folstein SE, Ross CA, Hayden MR (1996): Phenotypic characterisation of individuals with 30-40 CAG repeats in the Huntington's disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 59:16-22.
58. Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, Difiglia M (1997): Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 42:604-612.
59. Sathasivam K, Amaechi I, Mangiarini L, Bates GP (1997): Identification of an HD patient with a (CAG) 180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage. Hum Genet 99:692-695.
60. Scherzinger E, Lurz R, Turmaine M, Mangiarini L, Hollenbach B, Hasenbank R, Bates GP, Davies SW, Lehrach H, Wanker EE (1997): Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90:549-558.
61. Sharp AH, Love SJ, Schilling G, Li S-H, Li X-J, Bao J, Wagster MV, Kotzuk JA, Steiner JP, Lo A, Hedreen J, Sisodia S, Snyder SH, Dawson TM, Ryugo DK, Ross CA (1995): Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1065-1074.
62. Storey E, Beal MF (1993): Neurochemical substrates of rigidity and chorea in HD. Brain 116:1201-1223.
63. Stott K, Blackburn JM, Butler PJG, Perutz M (1995): Incorporation of glutamine repeats makes protein oligomerize: Implications for neurodegenerative diseases. Proc Natl Acad Sci USA 92:6509-6513.
64. Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel J-L (1995a): Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 10:104-110.
65. Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Sandou F, Weber C, David G, Tora L, Agid Y, Brice A, Mandel J-L (1995b): Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378:403-406.
66. Tukamoto T, Nukina N, Ide K, Kanazawa I (1997): Huntington's disease gene product, huntingtin, associates with microtubules in vitro. Brain Res Mol Brain Res 51:8-14.
67. Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP (1985): Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577.
68. Wanker EE, Rovira C, Scherzinger E, Hasenbank R, Walter S, Tait D, Colicelli J, Lehrach H (1997): HIP1: A huntingtin interacting protein isolated by the yeast two-hybrid system. Hum Mol Genet 6:487-495.
69. Wellington CL, Ellerby LM, Hackman AS, Margolis RL, Trifiro MA, Singaraja R, McCutcheon K, Salvesen GS, Propp SS, Bromm M, Rowland KJ, Zhang T, Rasper D, Roy S, Thornberry N, Pinsky L, Kakizuka A, Ross CA, Nicholson DW, Bredesen DE, Hayden MR (1998): Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 273:9158-9167.
70. Wells RD (1996): Molecular basis of genetic instability of triplet repeats. J Biol Chem 271:2875-2878.
71. Whetsell WO (1996): Current concepts of excitotoxicity. J Neuropathol Exp Neurol 55:1-13.
72. White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1997): Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet 17:404-410.
73. Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A (1995): Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 11:155-163.